Article Versions Notes

Kartolo A, Semenuk L, Feilotter H, Savage C, Boag A, Hopman W, Digby G, Mates M. Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of Palliative Systemic Therapy. Current Oncology. 2026; 33(1):42. https://doi.org/10.3390/curroncol33010042

Kartolo, Adi, Laura Semenuk, Harriet Feilotter, Colleen Savage, Alexander Boag, Wilma Hopman, Geneviève Digby, and Mihaela Mates. 2026. "Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of Palliative Systemic Therapy" Current Oncology 33, no. 1: 42. https://doi.org/10.3390/curroncol33010042

Kartolo, A., Semenuk, L., Feilotter, H., Savage, C., Boag, A., Hopman, W., Digby, G., & Mates, M. (2026). Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of Palliative Systemic Therapy. Current Oncology, 33(1), 42. https://doi.org/10.3390/curroncol33010042